FI102612B - Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 |heptako seenien ja niiden johdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 |heptako seenien ja niiden johdannaisten valmistamiseksi

Info

Publication number
FI102612B
FI102612B FI932035A FI932035A FI102612B FI 102612 B FI102612 B FI 102612B FI 932035 A FI932035 A FI 932035A FI 932035 A FI932035 A FI 932035A FI 102612 B FI102612 B FI 102612B
Authority
FI
Finland
Prior art keywords
heptacoses
tricyclo
stripping
derivatives
therapeutically useful
Prior art date
Application number
FI932035A
Other languages
English (en)
Swedish (sv)
Other versions
FI102612B1 (fi
FI932035A0 (fi
FI932035A (fi
Inventor
Karl Baumann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209815A external-priority patent/GB9209815D0/en
Priority claimed from GB939304927A external-priority patent/GB9304927D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI932035A0 publication Critical patent/FI932035A0/fi
Publication of FI932035A publication Critical patent/FI932035A/fi
Priority to FI982476A priority Critical patent/FI982476A0/fi
Application granted granted Critical
Publication of FI102612B1 publication Critical patent/FI102612B1/fi
Publication of FI102612B publication Critical patent/FI102612B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
FI932035A 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 |heptako seenien ja niiden johdannaisten valmistamiseksi FI102612B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209815A GB9209815D0 (en) 1992-05-07 1992-05-07 Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en) 1993-03-10 1993-03-10 Organic compounds

Publications (4)

Publication Number Publication Date
FI932035A0 FI932035A0 (fi) 1993-05-05
FI932035A FI932035A (fi) 1993-11-08
FI102612B1 FI102612B1 (fi) 1999-01-15
FI102612B true FI102612B (fi) 1999-01-15

Family

ID=26300836

Family Applications (2)

Application Number Title Priority Date Filing Date
FI932035A FI102612B (fi) 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 |heptako seenien ja niiden johdannaisten valmistamiseksi
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Country Status (25)

Country Link
US (1) US5514685A (fi)
EP (1) EP0569337B1 (fi)
JP (1) JP2788392B2 (fi)
KR (1) KR100292311B1 (fi)
CN (1) CN1037773C (fi)
AT (1) ATE155787T1 (fi)
AU (1) AU668152B2 (fi)
CA (1) CA2095659C (fi)
CY (1) CY2126B1 (fi)
CZ (1) CZ291773B6 (fi)
DE (1) DE69312386T2 (fi)
DK (1) DK0569337T3 (fi)
ES (1) ES2105193T3 (fi)
FI (2) FI102612B (fi)
GR (1) GR3024754T3 (fi)
HU (2) HUT66531A (fi)
IL (1) IL105607A (fi)
MY (1) MY109602A (fi)
NO (1) NO305865B1 (fi)
NZ (1) NZ247553A (fi)
PH (1) PH30456A (fi)
RU (1) RU2126009C1 (fi)
SG (1) SG47011A1 (fi)
SK (1) SK282061B6 (fi)
TW (1) TW330936B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
IL115742A (en) 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
KR100434682B1 (ko) 1994-10-26 2004-08-18 노바티스 아게 약학조성물
RU2214244C9 (ru) 1998-03-26 2020-07-29 Астеллас Фарма Инк. Препараты с замедленным высвобождением
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
CA2492989C (en) 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
KR100469917B1 (ko) * 2002-09-09 2005-02-02 (주)조은식품 구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) * 2005-12-16 2007-08-03 주식회사농심 조직감이 향상된 사출 스낵 및 그 제조 방법
CN102958935B (zh) * 2010-04-02 2015-12-09 爱尔兰詹森科学公司 大环整合酶抑制剂
ES2898849T3 (es) 2014-10-28 2022-03-09 Koushi Yamaguchi Medicamento para mejorar el síndrome de hipertensión inducida por el embarazo
EP3834826A4 (en) 2018-08-10 2022-07-27 Koushi Yamaguchi THERAPEUTIC AGENT FOR HUMORAL IMMUNITY-RELATED DISEASES IN THE MATERNO-FETAL RELATIONSHIP
US20220062245A1 (en) 2018-12-18 2022-03-03 Koushi Yamaguchi Agent for improving infertility, recurrent miscarriage, and state of pregnancy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) * 1984-12-03 1993-10-19 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0364031B1 (en) * 1988-10-12 1992-12-23 Merck & Co. Inc. Hydroxide mediated fk-506 rearrangement process
CA1316916C (en) * 1988-10-12 1993-04-27 David Askin Hydroxide mediated fk-506 rearrangement product
KR920700212A (ko) * 1989-06-14 1992-02-19 쟝 크라머·한스 루돌프 하우스 헤테로원자-함유 트리사이클릭 화합물
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
JP3644957B2 (ja) * 1991-09-05 2005-05-11 アボット・ラボラトリーズ 大環式イムノモジュレーター

Also Published As

Publication number Publication date
NO305865B1 (no) 1999-08-09
EP0569337B1 (en) 1997-07-23
RU2126009C1 (ru) 1999-02-10
FI982476A0 (fi) 1998-11-16
HUT66531A (en) 1994-12-28
IL105607A (en) 1998-01-04
FI102612B1 (fi) 1999-01-15
NZ247553A (en) 1995-07-26
HU9301190D0 (en) 1993-07-28
DK0569337T3 (da) 1998-01-19
KR940005631A (ko) 1994-03-22
CN1083486A (zh) 1994-03-09
FI932035A0 (fi) 1993-05-05
DE69312386T2 (de) 1998-01-29
SK43593A3 (en) 1995-07-11
NO931627L (no) 1993-11-08
CZ82993A3 (en) 1994-01-19
CY2126B1 (en) 2002-06-21
MY109602A (en) 1997-03-31
JPH0641144A (ja) 1994-02-15
CA2095659A1 (en) 1993-11-08
PH30456A (en) 1997-05-28
CA2095659C (en) 2005-08-09
KR100292311B1 (ko) 2001-09-17
SK282061B6 (sk) 2001-10-08
SG47011A1 (en) 1998-03-20
HU211135A9 (en) 1995-10-30
EP0569337A1 (en) 1993-11-10
GR3024754T3 (en) 1997-12-31
NO931627D0 (no) 1993-05-05
AU668152B2 (en) 1996-04-26
DE69312386D1 (de) 1997-08-28
ATE155787T1 (de) 1997-08-15
IL105607A0 (en) 1993-09-22
US5514685A (en) 1996-05-07
TW330936B (en) 1998-05-01
CZ291773B6 (cs) 2003-05-14
JP2788392B2 (ja) 1998-08-20
ES2105193T3 (es) 1997-10-16
FI932035A (fi) 1993-11-08
AU3839393A (en) 1993-11-11
CN1037773C (zh) 1998-03-18

Similar Documents

Publication Publication Date Title
SG47520A1 (en) New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
MX9304646A (es) Nuevas 7-(sustituido)-8-(sustituido)d-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinasy metodo para su produccion.
FI102612B (fi) Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 |heptako seenien ja niiden johdannaisten valmistamiseksi
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
YU70294A (sh) Kristalni hidranti derivati 3,4,4-trisupstituisanih-piperidinil-n-alkilkarbok silata, njihovi intermedijari i postupak za dobijanje
EG20279A (en) New derivatives of 3 arylpyrazoles used as fungicides
PL300068A1 (en) 9-(substituted glycil) amido-6-demethyl-6-deoxytetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts or metal complexes, pharmaceutical agent and veterinari agent
FI954718A0 (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
FI940769A0 (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI93863B (fi) Menetelmä kestävän teräksen valmistamiseksi
AU2578292A (en) 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
EP0458160A3 (en) Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents
DE69432756D1 (de) 1,3-oxazin-4-on-derivate, verfahren und zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
ITMI931019A1 (it) Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti
FI973644A (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
FI953106A0 (fi) Difuoripentapeptidijohdannaiset anti-inflammatorisina aineina
FI101817B1 (fi) Menetelmä suprajohtavien seosten valmistamiseksi
AU2704492A (en) Improvements in or relating to organic compounds
ITMI921593A0 (it) Articoli formati per uso biomedicale
FI950101A (fi) 4-oksa-1-atsabisyklo 3,2,0 -7heptanoni-johdannaiset kasvainten vastaisina aineina
FI912247A (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrrolo/2,3-b/indoliketonijohdannaisten valmistamiseksi
AU636033C (en) Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents
ZA913866B (en) Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents
AU5280098A (en) Benzylsulfide derivatives suitable for use as intermediates in the production of pesticides
FI974027A (fi) Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi eseretoleista

Legal Events

Date Code Title Description
FG Patent granted

Owner name: NOVARTIS AG

GB Transfer or assigment of application

Owner name: NOVARTIS AG

MM Patent lapsed